Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Noul Co. Ltd. (376930:KRX), powered by AI.
Noul Co. Ltd. is currently trading at ₩819. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Noul Co. Ltd. on Alpha Lenz.
Noul Co. Ltd.'s P/E ratio is -2.1.
“Noul Co. Ltd. trades at a P/E of -2.1 (undervalued) with modest ROE of -87.0%. 3Y revenue CAGR of 111.4% highlights clear growth momentum.”
Ask for details →Noul Co. Ltd. specializes in the development and provision of cutting-edge diagnostic and life science solutions. At the heart of its operations is the focus on molecular diagnostic technologies aimed at enhancing the efficiency and effectiveness of point-of-care testing. The company is recognized for its contributions to sectors including healthcare, research, and pharmaceuticals, providing critical tools and instruments that aid in the detection and monitoring of various diseases. By integrating advanced technology with user-friendly platforms, Noul is pivotal in streamlining diagnostic processes and improving patient outcomes. Its market presence underscores the growing demand for innovative diagnostic solutions in an increasingly health-conscious global environment. Founded on a mission to revolutionize diagnostic science, Noul Co. Ltd. plays a significant role in the medical device industry, contributing to advancements that support preventive healthcare and personalized medicine.
“Noul Co. Ltd. trades at a P/E of -2.1 (undervalued) with modest ROE of -87.0%. 3Y revenue CAGR of 111.4% highlights clear growth momentum.”
Ask for details →Noul Co. Ltd. (ticker: 376930) is a company listed on KRX in the Healthcare sector (Diagnostics & Research). It has approximately 139 employees. Market cap is $42.0B.
The current price is ₩819 with a P/E ratio of -2.11x and P/B of 1.64x.
ROE is -87.04% and operating margin is -392.03%. Annual revenue is $5.1B.